Advanced search
Publication Cover
HIV Clinical Trials Volume 7, 2006 - Issue 6
Submit an article Journal homepage
35
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

No Virological Failure in Semen During Properly Suppressive Antiretroviral Therapy Despite Subtherapeutic Local Drug Concentrations

Selwyn H. LoweDepartment of Internal Medicine Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam;International Antiviral Therapy Evaluation Center (IATEC)AmsterdamCorrespondence[email protected]
,
Annemarie M.J. WensingEijkman Winkler Institute Department of Medical Microbiology, Division of Virology, University Medical Center Utrecht;;Department of Internal Medicine Division of Acute Medicine and Infectious Diseases, University Medical Center Utrecht;
,
Jacqueline A.H. DrosteDepartment of Clinical PharmacyUniversity Medical Centre Nijmegen;;Nijmegen University Centre for Infectious Diseases; 7 Kennemer Gasthuis, Department of Internal Medicine, Haarlem;
,
Reinier W. ten KateKennemer Gasthuis Department of Internal Medicine, Haarlem;
,
Suzanne JurriaansDepartment of Human RetrovirologyCenter of Infection and Immunity Amsterdam, Academic Medical Centre, University of Amsterdam, The Netherlands
,
BurgerDepartment of Clinical PharmacyUniversity Medical Centre Nijmegen;
,
Jan C.C. BorleffsDepartment of Internal Medicine Division of Acute Medicine and Infectious Diseases, University Medical Center Utrecht;
,
Joep M.A. LangeDepartment of Internal Medicine Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam
&
Jan M. PrinsDepartment of Internal Medicine Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Centre, University of Amsterdam, Amsterdam;International Antiviral Therapy Evaluation Center (IATEC)Amsterdam
 show all
Pages 285-290 | Published online: 06 Jan 2015

REFERENCES

  • Lowe SH, Sankatsing SU, Repping S, et al. Is the male genital tract really a sanctuary site for HIV? Arguments that it is not. AIDS. 2004;18:1353–1362.
  • Taylor S, Boffito M, Vernazza PL. Antiretroviral therapy to reduce the sexual transmission of HIV. J HIV Ther. 2003; 8:55–66.
  • Lowe SH, Wensing AMJ, Hassink EAM, et al. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). HIV Clin Trials. 2005;6:235–245.
  • Barroso PF, Schechter M, Gupta P, et al. Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med. 2000;133:280–284.
  • Liuzzi G, Chirianni A, Bagnarelli P, Clementi M, Piazza M. A combination of nucleoside analogues and a protease in-hibitor reduces HIV-1 RNA levels in semen: implications for sexual transmission of HIV infection. Antivir Ther. 1999;4: 95–99.
  • Eron JJ, Vernazza PL, Johnston DM, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS. 1998;12:F181–F189.
  • Kroodsma KL, Kozal MJ, Flamed KA, Winters MA, Merigan TC. Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differ-ences in semen and blood HIV-1 RNA and proviral DNA. J Infect Dis. 1994;170: 1292–1295.
  • Notermans DW, de Wolf F, Oudshoorn P, et al. Evaluation of a second-generation Nucleic Acid Sequence-Based Amplification Assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations. AIDS Res Hum Retroviruses. 2000;16:1507–1517.
  • Back D, Blaschke T, Boucher C, et al. Therapeutic drug monitoring guidelines: therapeutic ranges for antiretroviral drugs. 2003. Available at: www.HIVPharmacology.com.
  • Droste JA, Verweij-Van Wissen CP, Burger DM. Simulta-neous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chro-matography. Ther Drug Monit. 2003;25:393–399.
  • Aarnoutse RE, Grintjes KJ, Telgt DS, et al. The influence of efavirenz on the pharmacokinetics of a twice-daily combi-nation of indinavir and low-dose ritonavir in healthy volun-teers. Clin Pharmacol Ther. 2002;71:57–67.
  • Taylor S, Back DJ, Drake SM, et al. Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. Antimicrob Chemother. 2001;48:351–354.
  • Taylor S, Back DJ, Workman J, et al. Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS. 1999;13:859–860.
  • Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2003;47:238–243.
  • Schuurman R, Nijhuis M, van Leeuwen R, et al. Rapid changes in human immunodeficiency virus type I RNA load and appearance of drug resistant virus populations in per-sons treated with lamivudine (3TC). J Infect Dis. 1995;171:1411–1419.
  • Foudraine NA, de Jong JJ, Jan WG, et al. An open random-ized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine. AIDS. 1998;12:1513–1519.
  • Gisslen M, Hagberg L. Antiretroviral treatment of central nervous system HIV-1 infection: a review. HIV Med. 2001;2: 97–104.
  • Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65:208–231.
  • Zhang H, Dornadula G, Beumont M, et al. Human immuno-deficiency virus type 1 in the semen of men receiving highly active anti retoviral therapy. N Engl J Med. 1998;339:1803–1809.
  • Dornadula G, Zhang H, VanUitert B, et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA. 1999;282:1627–1632.
  • Xu C, Politch JA, Mayer KH, Anderson DJ. Human immu-nodeficiency virus type-1 episomal cDNA in semen. AIDS Res Ther. 2005;2:9.
  • Vernazza PL. HIV in semen: still more to be learned. AIDS Res Ther. 2005;2:11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.